BRBR - BellRing Brands, Inc.

BRBR

$12.75 +0.00 (+0.00%)

Pre-Market: $12.10 0.65 (-5.10%)

Last updated: Jul 15, 2026 09:23

52-Week Range

$12.10

$7.82 $12.10 $59.10

Fundamentals Overview

BellRing Brands, Inc. is near the low of its 52-week range with low valuation, experiencing significant downward pressure today.

Valuation low

P/E 9.1 P/S 0.6

Intrinsic value (DCF)

+859.3% upside vs price

Profitability

Net margin 6.8%

Risk (Beta)

0.52 — lower vol

Earnings & growth

EPS $1.33 Rev +11.4% Profit -22.4% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 56% confidence Risk: Lower Volatility — Beta 0.52. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +859.3% upside vs price · Analyst grade: B

Pressures (Sell):

Sentiment weakening (4 downgrades) · 3M vs S&P 500: -29.5% · 3M vs Consumer Defensive sector: -21.7%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$1.41B

P/E (TTM)

9.08

EPS (TTM)

$1.33

Dividend Yield

N/A

52-Week Range

$7.82 - $59.10

Volume vs Avg

N/A

Beta

0.52

About

BellRing Brands Inc., along with its various subsidiaries, is a provider of diverse nutritional products, serving both the United States and international markets. The company's main offerings are protein-fortified ready-to-drink shakes and powdered protein supplements, which are primarily marketed under its well-known Premier Protein and Dymatize labels. These items are made accessible to consumers through a wide range of distribution points, including warehouse clubs, grocery stores, pharmacie...

Sector: Consumer Defensive

Headquarters: US

Employees: 530

IPO Date: Oct 2019

Website: bellring.com

Beta: 0.52 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 8, Equal Weight: 1, Hold: 3, Market Perform: 1, Neutral: 6, Outperform: 1, Overweight: 10.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $116.08; current price is $12.10. That’s a +859.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	9.08
DCF value (model)	$116.08 (859.3% upside)
PEG (TTM)	N/A
P/B (TTM)	N/A
P/S (TTM)	0.6
P/FCF (TTM)	7.55
Liquidity & enterprise
Current Ratio (TTM)	2.52
Quick Ratio (TTM)	1.15
Cash Ratio (TTM)	0.11
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	6.78%
Gross margin (TTM)	28.87%
Operating margin (TTM)	11.57%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for BRBR.

Analyst Sentiment at a Glance

B Sentiment Weakening

Buy 8Equal Weight 1Hold 3Market Perform 1Neutral 6Outperform 1Overweight 10

0 upgrades, 4 downgrades

Price Target Consensus

Current $12.10

Median $13.50

Consensus $18.75

Low consensus $11.00

High consensus $32.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Stephens & Co.	maintain	Overweight	Overweight	2026-07-09
DA Davidson	maintain	Buy	Buy	2026-05-15
Barclays	maintain	Overweight	Overweight	2026-05-07
Bernstein	downgrade	Outperform	Market Perform	2026-05-06
JP Morgan	maintain	Overweight	Overweight	2026-05-06
TD Cowen	maintain	Hold	Hold	2026-05-06
Stifel	maintain	Buy	Buy	2026-05-06
Morgan Stanley	downgrade	Overweight	Equal Weight	2026-05-06
UBS	maintain	Neutral	Neutral	2026-05-06
Morgan Stanley	maintain	Overweight	Overweight	2026-04-23
JP Morgan	maintain	Overweight	Overweight	2026-04-22
Barclays	maintain	Overweight	Overweight	2026-04-14
B of A Securities	maintain	Neutral	Neutral	2026-04-10
UBS	maintain	Neutral	Neutral	2026-04-07
Jefferies	maintain	Buy	Buy	2026-03-16
Mizuho	maintain	Outperform	Outperform	2026-03-05
Barclays	maintain	Overweight	Overweight	2026-02-05
DA Davidson	maintain	Buy	Buy	2026-02-05
Stifel	maintain	Buy	Buy	2026-02-04
DA Davidson	maintain	Buy	Buy	2026-02-04
DA Davidson	maintain	Buy	Buy	2026-01-28
Morgan Stanley	maintain	Overweight	Overweight	2026-01-16
UBS	maintain	Neutral	Neutral	2026-01-14
TD Cowen	maintain	Hold	Hold	2026-01-08
B of A Securities	maintain	Neutral	Neutral	2025-12-19
DA Davidson	maintain	Buy	Buy	2025-11-20
TD Cowen	downgrade	Buy	Hold	2025-11-20
B of A Securities	downgrade	Buy	Neutral	2025-11-19
Morgan Stanley	maintain	Overweight	Overweight	2025-11-19
Barclays	maintain	Overweight	Overweight	2025-11-19